Moreover, research has predominantly focused on broadly expressed pan-cancer biomarkers, such as PTK7, nucleolin, and EGFR [[221], [222], [223]], while studies specifically addressing biomarkers unique to rare cancers remain scarce. This evidence concerns the gene EGFR and cancer.